Dust bin. Sue . Thats right. Thats coming up in a few minutes. But as you mentioned the president is meeting silicon valleys top tech titans. Ceos from google and apple and facebook among them. The president as you mentioned wants to talk about improving the Health Care Website but these ceos are focused more on the governments spying program. Amman javers is following the still developing story for us from washington. We have something a little interesting going on right now. The ceo meeting with the president in the roosevelt room here at the white house started at about 10 45 eastern time here in washington and it is still going on at this hour. We got cameras into the meeting to see some of the opening moments of that meeting and the president reportedly joking with the ceo of netflix about whether or not he brought copies of the new season of house of cards before they got down to the Serious Business of this conversation today. But they are still in there over two hours in this meeting so clearly something of substance being discussed. Just what it is, though, we dont know. The white house spokesman is not saying at this point. Were hoping to get some kind of a read out on this meeting when it does break up and well bring that to you as soon as we have it. Were getting news out of the white house in terms of whos going to take over for jeff zion to handle the healthcare. Gov rollout so troubled and botched. Jeff had been the point guy leading that. Were told by the white house that a man named Kirk Dell Ben nay a former microsoft executive is going to take over that role here at the white house and sort of honcho the website rollout from here on out because jeff is taking over at the National Economic council. They needed to move him out of the way and bringing kirk in, sue. Amman, before we letgo, talk to me a more about the battle that seems to be brewing between the white house and media specifically when it comes to access, access to the president and access to information. What can you tell us . Yeah, sue. There have been some real moments of frustration for the White House Press corps, folks particularly still photographers are upset that what the white house has been doing a lot lately is bringing their own white house photograph per into events but barring actual press photographers from covering those same events. There was a flashpoint just last week on air force one on the trip to south africa for the Nelson Mandela service, in which there was a photogenic moment, a number of expresident s on air force one with president obama, reporters not allowed to cover that but the white house photographer did cover that. We had a chance to talk to the president of the White House Correspondents Association and we asked him why its so important to reporters that independent reporters be allowed to come in and cover these events. Take a listen. A great example is in 1981 when Ronald Reagan was shot, the white house released a photograph of him in the hospital standing with nancy reagan at his side in his bath robe in his pajamas noents reassure the country. We found out later the photo was cropped but they cropped out was the iv tubes running up and down just outside the lens. A photo journalist or cameraman would have gotten that. The key is for reporters that cover the white house, they want independent reporters, people arent on the white houses payrolls to be covering these events. Absolutely. Thank you very much. Breaking news in the bond market. The twoyear note going up for auction. Rick santelli is tracking the action. Whats demand like, ricky . Hey. It gets an a for apple and, of course, this is a short maturity and short maturities ought to be nailed to the wall. Not a lot of volatility no matter what the fed does with taper and this, indeed, seemed to be the case so an a is the grade. The yield. 345 below the one issued price trading around 35 basis points. It has the best bid to cover since november of 12 at 3. 77, although that equal january of 2013. The indirects were a little light at 21. 5 versus 25 . And the directs were a little heavy at 30. 2, but tyler, its a solid, solid auction and, of course, tomorrows auction will be a bit early for obvious fed statement and press conference reasons. Back to you. Very interesting day ahead. Rick santelli will be with us, of course, throughout the day today and into tomorrow. Meanwhile, the Senate Voting on that budget deal that was reached in the house and passed over there last week, our chief washington correspondent john harwood has the details. Whats the timeline now . Is it all done, jon . Not all done but its in the process of being done. Senate and the congress is giving markets the kind of present they wanted for christmas, that is a little calm and stability and not any more continuation of the crisis atmosphere. Last week the white house passed this Patty Murray Paul Ryan budget deal. Today the senate with 67 votes, cleared a potential filibuster hurdle, 12p areps joining with all 55 democrats. This is a noncontroversial baby step kind of deal, but there had been some suspense as to whetherp areps were going to go along, enough of them to clear a potential filibuster because it does raise the shortterm spending by adjusting the sequester caps. This is now done. In a debate period where senators are going to the floor, stating their position for the record before the final vote, that is now scheduled to happen tomorrow evening. Thats wednesday evening, unless both sides agree to yield back the remaining debate time, get on to other business. Thats not expected currently, so were on a track for the budget deal to finally get passed and sent to the president of the United States tomorrow evening. Tyler . Jon, thank you very much. You know, this is a big day for us business news, Financial News wonks because the fed is kicking off a twoday meeting on Interest Rates. It doesnt get any better than this, does it, steve . We could have a senate vote on janet yellen this week if he sh becomes the next fed chief. Steve liesman here with the results of our fed survey. I described for the radio broadcasters a few moments ago janet yellen is Ben Bernankes sort of monetary soulmate. Fair or not fair is. Thats a good point and lead in, tyler, because thats what our panel believes. We surveyed 42 economists and strategists in our cnbc fed survey and i want to show you, did a double take on this, compared to bernanke is yellen going to be much more dovish, no different, hawkish, et cetera if i originally thought they thought she was more dovish but if you look at it, its come from a decline compared to the last survey and those that think shes going to be much more dovish, no different here, as well, and nobody thinks shes going to be much more hawkish. Its interesting. I think they think yellen will be much more like tyler was saying, much more like bernanke. We asked people as bernanke on his way out here, what they thought of qe1, qe2, qe3, essential, harmful, not needed, no help here. Overwhelming support it was essential. There is no orange bar. Nobody thought qe3 was essential. How about helpful . What you find here is, okay, now we get about 28, 29 think that qe3 was helpful. Neutral. As you fill this in see more and more opposition, harmful, not needed the answers to qe3 where over here you see all the support for, qe3. How about grading bernanke . Overall he gets a b. A little bit up from the bminus in our last su va here. Some of the comments we got from our respondents here. Those giving him an a included you can see steven gallagher, makes a kind of critical comment. Time may tell us Monetary Policy took pressure off fiscal policy and therefore contributed to poor fiscal policy, still gives him an a. The next person giving him an a, stuart hoffman. Calls him a national hero. Alan blinder from princeton, a little more critical, said without lehman he would have given him an a. How about some who give him a b. A for the crisis. Incomplete for 2010 to 2013 according to barry as the cost will be realized over time. A lot of commentary like that and this, from jon riding who says a for handling the financial crisis but a d for the Monetary Policy leading up to the crisis. Too easy on the way and the continuation of qe. Lot of comments on that. Very interesting. Your view tomorrow, will we get the taper or not . I think its lined up. I think the fed if it was a close call in september, when i look at the data right now i think it should be a slam dunk. If im wrong im wrong in january. I will be right in january. Cnbc your place to turn for live coverage of the fed decision tomorrow. It will be right here on cnbc 1 50 eastern time tomorrow followed by fed chair Ben BernankesNews Conference at 2 30. Thanks, ty, very much. With the fed expected to start tapering soon, maybe tomorrow, maybe january, how should investors position themselves going into the new year . We welcome back our power players, andrew is managing director and senior Portfolio Manager at Morgan StanleyWealth Management with me here and gary is chief macro strategist at wells fargo advisoradvisors. Welcome to you both. Andrew, you do not think they are going to start tapering tomorrow . Im not an economist. Im a Portfolio Manager, but it would seem at his last meeting it probably is not likely and were probably looking out to next year. But the story line of this year is all the people that got too bearish in anticipation of tapering thats been a mistake so far. A big mistake given how this market has run. How do you play this market going into the new year with the view in your opinion that the fed probably wont taper tomorrow . Well, you have to look at the playbook and the playbook says when the fed does change policy, markets get a little bit more volatile and so i think thats coming, but im not sure its right around the corner. In the meantime i think there are a lot of very good Growth Stocks at reasonable multiples and i think thats what we need to focus on. Gary, would you agree with that and what do you think, if anything, the fed might do tomorrow some. Well, sue, i think that, you know, the fed has said its going to happen soon, within a few months, so if its not tomorrow its early next year. The important thing is, its not going to be a surprise. Were all anticipating its going to happen in the near future and i think for that reason, its probably not going to have as big a Market Impact as the sort of surprise discussion of taper asking last spring. So, you know, were telling people that, you know, were not expecting a sharp increase in yields and maybe we get a little volatility off this but probably not a lot. You know, andrew, if you had to pick sectors that still look attractive to you, given what weve just laid out, where would you be putting cash to work or where are you putting cash to work . I know theres weakness near term because of yearend selling and traditionally we get kind of the bounce on the low quality stocks in january. I would be careful with that because i dont think some of the health care, growth names, yes, some of the ubber growth names theyve done very well and theyre expensive but theres a lot of pretty good health care, Technology Stocks i dont think are expensive. I think theyll continue to do well in 2014 until we get higher multiples on true Growth Stocks. Gary, weigh in on where you would put cash to work right now . Sue, we like the stock market. We do think well get a decent year next year, probably not as good as this year but we favor the cyclical sectors. With the economy continuing to improve and the outlook we believe is still positive, that you ought to be overweighting things like consumer discretionaries, industrials and tech sector. Thank you both. Merry christmas, maihappy new y. Ty to you. New data out right now on in store foot traffic this Holiday Shopping season. Courtney reagan at Queens Center mall in elmhurst, new york. Hi. Hi, tyler. The winter storm that dropped snow from missouri to main sidelined shoppers with just a couple days left to go until christmas. According to shopper track, in store shopper traffic fell nearly 26 on saturday alone. Brick and mortar sales, those are again sales that are only done in store, fell 5. 4 . Lower but much less in that traffic. Some shoppers got ahead of the storm, in store brick and mortar sales according to shopper track up 3. 3 for friday after the storm, sundays in store brick and Mortar Stores down, making the weekend down 1. 5 for in store. The big question that retailers are white knuckling are those shoppers going to make up the difference this week and double down or are those sales lost for good . I got to tell you, inside this mall, not a lot of foot traffic for eight days until christmas. Back to you. All right. Courtney, thanks very much. Two big headlines that could have huge implications for the drug industry. Patients and shareholders. Sara, seema moody, both on the case. Sara, you first. Conflict of interest maybe in the pharma industry. Doctors have gotten paid by Drug Companies to promote their drugs, but that may all be about to change. Coming up, well tell you how one pharma giant is changing the script on doctor pay. And concerning data on vitamins and lack of benefits they provide. Will this impact consumer demand . We discuss next on power lunch. [ male announcer ] the new new york is open. Open to innovation. Open to ambition. Open to bold ideas. Thats why new york has a new plan dozens of tax free zones all across the state. Move here, expand here, or start a new business here and pay no taxes for ten years. Were new york. If theres something that creates more jobs, and grows more businesses. Were open to it. Start a taxfree business at startupny. Com. Take a look at shares of 3 m a big stock to watch today up better two and a third percent. Raising its dividend 35 to 85. 5 a share for 2014 and increasing its share buybacks over the next few years and plans to spend between 5 and 10 billion on acquisitions through the year 2017 and that stock up 40 this year alone. Stick that one on the refrigerato refrigerator, ty. This caught my eye, big news, glaxo, one of the largest Pharmaceuticals Going to stop paying doctors to promote its drugs and secondly as you may have heard yesterday regulators say vitamins are pretty much useless. Sara first, first welcome, good to have you with us. Good to be here, thank you. What does this mean for glaxo and shareholders . Theyre breaking the mold here. Glaxosmithkline, british giant pharmaceuticals makes antidepressants and Consumer Products like aqua fresh and nick core rest, tums, the first to stop paying krs to promote drugs. For decades this was an Industry Standard practice but its raising concerns about conflicts of interest. It is with this announcement going to stop tying compensation for Sales Representatives to the number of prescriptions written for the drugs that they make. The question is, why is glaxo making this move . I talked to glaxo spoke people and they tell me theyre trying to address the perception its not in the patients best interest to have these kind of doctor pay relationships, but we should note while glaxo claims its following industry changes, responding to shifts in societal demands, it does have a reputation to repair. Glaxo is at the center of a corruption investigation in china over allegations it bribed hospitals, doctors and officials and they paid a huge fine, right . And also in the United States paid a 3 billion record fine last year to settle allegations it marketed drugs for unapproved uses. Off label use. Now glaxo is one player in this business. True. Not the only one. Will others likely follow suit . Analysts are suggesting that yes, glaxo could be a trendsetter here. Certainly theres pressure on the industry right now and other pharma giantses have paid to settle similar cases. Under obama care, all payments to doctors have to be disclosed, made public next year and analysts told cnbc earlier that all the Major Companies are going to have to do it because regulators and politicians are increasingly focused on it. Astrazeneca has been touting its policy in 2011 to improve ethics around doctor pharma relationships here, got rid of payments for doctors to attend international meetings, but none of the others have really moved. Interesting to watch some of the other names, j j, merck, we reached out to no comment there. Well watch to see what they do on the front. The change in the Business Model and the way medicines were prescribed and sold. A lot of attention on this one. Thanks very much. All right. Lets move on now. Seema, this could be a pretty bitter pill for lots of people to swallow. Those especially who take vitamins. What is going on here and why now . Heres the deal, medical experts revealed data on if we should take vitamins and here is their bottom line. I generally dont recommend vitamins. I recommend healthy dietary patterns and regular exercise because its unnecessary. Dr. Miller and other researchers cowrote a bold editorial that highlights the lack of benefits in taking vitamins and mineral supplements an how they may be even harmful. Whats the solution . Follow what your mother probably told you, which is to have a well balanced nutritious diet. Not clear whether people will take dr. Millers advice because the vitamin and supplement industry has been a fastgrowing one. In fact, euro star expected to reach 28 billion by 2017. Analysts saying one of the main drivers has been the aging baby boomer population. Gnc holdings, nu skin, herbal life had a significant footing in the vitamin and suppl